ERIKA WOODFOX: Open Payments
NPI 1982055257 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 23 payments from 9 companies in 2025. Trend: 2023 $890 · 2024 $411 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $293 |
| Novo Nordisk Inc | 4 | $72 |
| Lilly USA, LLC | 4 | $72 |
| Amgen Inc. | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| SANOFI PASTEUR INC. | 1 | $25 |
| ABBVIE INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: FARXIGA, BREZTRI, MOUNJARO, Wegovy, REPATHA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, GVOKE HYPOPEN, VRAYLAR.
Industry payments across NC — which companies pay providers there.
